The U.S. Federal Trade Commission has requested more information from two of the nation’s largest funeral home operators in its examination of whether their impending merger will diminish competition in the funeral home industry.
A federal judge has tossed a private securities fraud class action suit against Cell Therapeutics Inc., which claimed the company’s officers made false statements relating to the success of its lung cancer drug XYOTAX.
In the wake of last month’s massive crackdown on an acrylic glass cartel by European regulators, a group of chemical companies is facing similar charges on this side of the Atlantic in a new class action alleging the companies conspired to fix the prices of acrylic glass and plastics.
The California Public Employee’s Retirement System has appealed a decision that removed the New York Stock Exchange as a defendant in a lawsuit alleging that the exchange aided several investment banks in executing fraudulent trading schemes.
Just one week after its initial public offering, Internet phone company Vonage Holdings Corp. has been hit with a class action suit alleging the company made false and misleading statements in an effort to entice potential investors into purchasing shares of the company’s stock.
Three months after a crucial stay was lifted, the noteholders of bankrupt financial services outfit Thaxton Group Inc. have reached a $10 million partial class action settlement over the allegedly fraudulent sale of $120 million worth of debt to individuals.
In a setback for Infineon Technologies AG, a California district court has denied the German semiconductor maker’s attempt to dismiss a U.S. class action on behalf of shareholders who claimed Infineon inflated its share price through cartel deals.
Shareholders have amended their class action complaint against the executives, underwriters, and auditors of Italian dairy giant Parmalat SpA, adding allegations that target the company itself.
In a bid to avoid a criminal indictment in the United States, Austrian lender Bawag PSK Group has settled out of court with federal regulators for an amount that may exceed $600 million for its alleged role in the collapse of futures broker Refco Inc.
New York State Comptroller Alan G. Hevesi is asking a federal judge to remove recently indicted law firm Milberg Weiss as counsel for the lead plaintiff in a class action securities suit against Bayer AG.
The federal judge overseeing a class action securities suit against Global Crossing has granted preliminary approval to a settlement agreement that may bring the case to a close.
Attorneys in Canada are noting a surge in antitrust private class actions as the plaintiffs bar becomes more established and aggressive in filing cases.
Three banks will pay $6.6 billion to settle charges that they helped now-defunct Enron Corp. camouflage losses, bringing the total settlement value in the Enron case to a whopping $7.3 billion.
Inquests into questionable stock options practices at several high-tech companies have prompted a slew of derivative suits, as shareholders claim that boards of directors are looking the other way as executives manipulate their options grants to reap millions.
As MasterCard Inc. debuts on the New York Stock Exchange as a public entity Thursday, the second-largest credit card company is already facing a new challenge over its initial public offering from an ongoing lawsuit.
Despite requests from software maker Veritas Software Corp. for dismissal, a federal judge on Tuesday stated that a shareholder class action lawsuit over the company’s 2003 and 2004 financial results could go ahead.
Austrian lender Bawag PSK Group may pay as much as $600 million to settle allegations made by authorities in the United States considering criminal indictments against the bank for its alleged involvement in the collapse of futures broker Refco Inc.
Retail giant Sears Roebuck & Co. has agreed to pay $215 million to settle a long-running shareholder class-action lawsuit that accused the company of concealing poor profitability at its former credit card unit.
The whirlwind of litigation involving DRAM technology will not abate any time soon, despite a federal judge's preliminary approval last week of a $160 million settlement to be paid by the world’s top memory-chip makers.
Things have not been looking healthy lately for UnitedHealth Group Inc. The healthcare provider was already under fire from the SEC for possible backdating, and now finds itself dealing with a class action lawsuit alleging securities fraud.